DBPR108
DBPR108 is an orally active, dipeptide-based DPP4 inhibitor with an IC50 of 15 nM, demonstrating high selectivity as it does not inhibit DPP8 or DPP9. This compound is a valuable research tool for investigating DPP4 function in metabolic diseases, including diabetes, in both in vitro enzymatic assays and in vivo pharmacological studies.
Product Specifications
CAS Number
1186426-66-3
Product Name Alternative
Dipeptidyl Peptidase, DPP-4, DPP4, DPP, inhibit, Inhibitor, DBPR108, DBPR-108, DBPR 108
Field of Research
Protein Biochemistry
Purity
99.65% (May vary between batches)
Solubility
DMSO:≥ 25 mg/mL (77.07 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.17 mM)
Smiles
CC (C) (CC (=O) N1CCCC1) NCC (=O) N1C[C@@H] (F) C[C@H]1C#N
Molecular Formula
C16H25FN4O2
Molecular Weight
324.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
366947 200 µL
CYP51A1 (Lanosterol 14-alpha Demethylase, CYP51A1, CYPL1, CYPLI, Cytochrome P450 51A1, Cytochrome P450, Family 51, Subfamily A, Polypeptide 1, Cytochrome P450-14DM, Cytochrome P45014DM, Cytochrome P450L1, Cytochrome P450LI, LDM, Sterol 14-alpha Demethylase)
Sign In for Pricing
View Details 
